| 2026-05-29 | 8-K | 10.1 | Acadia Pharmaceuticals Inc. 2024 Equity Incentive Plan, as amended. |
|---|
| 2026-05-07 | 10-Q | 10.1 | Non-Employee Director Compensation Policy, effective March 3, 2026. |
|---|
| 2026-02-26 | 10-K | 10.53 | Master Commercial Manufacturing Services Agreement, dated December 10, 2025, by and between the Registrant and Halo Pharmaceutical, Inc. |
|---|
| 2026-02-26 | 10-K | 10.52 | Commercial Supply Agreement, dated February 22, 2018, by and between the Registrant and Catalent Pharma Solutions, LLC, as amended by Amendment No. 1 dated May 1, 2019 and Amendment No. 2 dated May 29, 2020. |
|---|
| 2026-02-26 | 10-K | 10.25 | Registration Rights Agreement, dated February 24, 2026, among the Registrant and the investors listed on Schedule A thereto. |
|---|
| 2025-08-07 | 10-Q | 10.5 | Forms of Standard Performance Stock Unit Grant Notice and Performance Stock Unit Agreement under the Acadia Pharmaceuticals Inc. 2024 Equity Incentive Plan. |
|---|
| 2025-08-07 | 10-Q | 10.4 | Forms of Standard Performance Stock Unit Grant Notice and Performance Stock Unit Agreement under the Acadia Pharmaceuticals Inc. 2024 Inducement Plan. |
|---|
| 2025-08-07 | 10-Q | 10.3 | Amendment No. 1 to Lease and Lease Agreement, dated May 15, 2025, between the Company and Boston Properties Limited Partnership. |
|---|
| 2025-08-07 | 10-Q | 10.2 | Lease and Lease Agreement, dated May 15, 2025, between the Company and 210 Associates Limited Partnership. |
|---|
| 2025-05-08 | 10-Q | 10.1 | Non-Employee Director Compensation Policy, effective April 14, 2025. |
|---|
| 2025-02-27 | 10-K | 10.43 | Asset Purchase Agreement dated November 5, 2024 with respect to sale of a priority review voucher. |
|---|
| 2025-02-27 | 10-K | 10.31 | Lease Agreement, effective October 4, 2018, by and between the Registrant and Kilroy Realty, L.P. |
|---|
| 2025-02-27 | 10-K | 10.30 | License Agreement, dated August 6, 2018, by and between the Registrant and Neuren Pharmaceuticals Ltd. |
|---|
| 2025-02-27 | 10-K | 10.16 | Employment Offer Letter, dated November 15, 2024, by and between the Registrant and Thomas Garner. |
|---|
| 2024-11-07 | 10-Q | 10.6 | Forms of Standard Performance Stock Unit Grant Notice and Performance Stock Unit Agreement under the Acadia Pharmaceuticals Inc. 2024 Inducement Plan. |
|---|
| 2024-09-23 | 8-K | 10.2 | Employment Agreement, dated September 23, 2024, by and between the Company and Catherine Owen Adams. |
|---|
| 2024-09-23 | 8-K | 10.1 | Executive Transition Agreement, dated September 23, 2024, by and between the Company and Stephen R. Davis. |
|---|
| 2024-08-07 | 10-Q | 10.9 | Employment Offer Letter, dated February 22, 2024, between the Registrant and Elizabeth H. Z. Thompson. |
|---|
| 2024-05-09 | 10-Q | 10.3 | Forms of Performance Stock Unit Grant Notice and Performance Stock Unit Award Agreement under Acadia Pharmaceuticals Inc. 2010 Equity Incentive Plan. |
|---|
| 2024-05-09 | 10-Q | 10.2 | Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under Acadia Pharmaceuticals Inc. 2010 Equity Incentive Plan. |
|---|
| 2024-05-09 | 10-Q | 10.1 | Forms of Nonstatutory Stock Option Grant Notice and Stock Option Agreement under Acadia Pharmaceuticals Inc. 2010 Equity Incentive Plan. |
|---|
| 2024-02-28 | 10-K | 10.38 | Commercial Supply Agreement, dated March 1, 2023, by and between the Registrant and CoreRx Inc., as amended by Amendment No. 1, dated August 1, 2023. |
|---|
| 2024-02-28 | 10-K | 10.37 | Product Agreement, effective May 1, 2022, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2024-02-28 | 10-K | 10.36 | Commercial Supply Agreement, dated December 15, 2021, by and between the Registrant and F.I.S. Fabbrica Italiana Sintetici S.p.A. |
|---|
| 2024-02-28 | 10-K | 10.35 | Master Commercial Supply Agreement, dated November 16, 2022, by and between the Registrant and Corden Pharma Bergamo S.p.A. |
|---|
| 2024-02-28 | 10-K | 10.20 | Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2024-02-28 | 10-K | 10.19 | Second Amendment to Product Agreement, dated October 6, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2024-02-28 | 10-K | 10.18 | First Amendment to Product Agreement, dated April 25, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2024-02-28 | 10-K | 10.17 | Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2024-02-28 | 10-K | 10.13 | Employment Offer Letter, dated January 12, 2024, between the Registrant and Jennifer Rhodes. |
|---|
| 2024-02-28 | 10-K | 10.5 | Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Acadia Pharmaceuticals Inc. 2010 Equity Incentive Plan. |
|---|
| 2023-08-03 | 10-Q | 10.1 | Joint Venture and License Agreement, dated July 13, 2023, by and between the Registrant and Neuren Pharmaceuticals Ltd. |
|---|
| 2023-02-28 | 10-K | 10.33 | Lease Agreement, effective May 15, 2018, by and between the Registrant and Boston Properties Limited Partnership. |
|---|
| 2023-02-28 | 10-K | 10.12 | Employment Offer Letter, dated December 19, 2022, between the Registrant and Doug Williamson. |
|---|
| 2022-11-03 | 10-Q | 10.3 | Attachment #4, Attachment #5 and Attachment #6, each dated May 12, 2017, to the Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates |
|---|
| 2022-11-03 | 10-Q | 10.2 | Change Order #1 to Master Services Agreement Attachment #1, dated January 3, 2017, by and between Acadia Pharmaceuticals GmbH and Siegfried AG |
|---|
| 2022-11-03 | 10-Q | 10.1 | Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates, and Attachment #1, Attachment #2 and Attachment #3 |
|---|
| 2022-08-09 | 10-Q | 10.1 | Equity Incentive Plan, as amended. |
|---|
| 2022-03-01 | 10-K | 10.11 | Employment Offer Letter, dated April 28, 2020, between the Registrant and Mark Schneyer. |
|---|
| 2022-03-01 | 10-K | 10.9 | Employment Offer Letter, dated June 26, 2018, between the Registrant and Brendan Teehan. |
|---|
| 2021-05-06 | 10-Q | 10.4 | Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2021-05-06 | 10-Q | 10.3 | Second Amendment to Product Agreement, dated October 6, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2021-05-06 | 10-Q | 10.2 | First Amendment to Product Agreement, dated April 25, 2016, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2021-05-06 | 10-Q | 10.1 | Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2021-02-25 | 10-K | 10.11 | Employment Offer Letter, dated April 2, 2018, between the Registrant and Elena Ridloff. |
|---|
| 2020-11-04 | 10-Q | 10.1 | Attachment #7, dated September 30, 2020, to the Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates. |
|---|
| 2020-05-08 | 10-Q | 10.2 | Second Amendment to Office Lease, dated March 12, 2020, between the Registrant and Kilroy Realty, L.P.* |
|---|
| 2020-05-08 | 10-Q | 10.1 | First Amendment to Office Lease, dated December 23, 2019, between the Registrant and Kilroy Realty, L.P.* |
|---|
| 2019-02-27 | 10-K | 10.27 | Lease Agreement, effective October 4, 2018, by and between the Registrant and Kilroy Realty, L.P. |
|---|
| 2019-02-27 | 10-K | 10.26 | License Agreement, dated August 6, 2018, by and between the Registrant and Neuren Pharmaceuticals Ltd. |
|---|
| 2018-11-06 | 10-Q | 10.1 | Employment Offer Letter, dated July 2, 2018, between the Registrant and Austin D. Kim. |
|---|
| 2018-08-08 | 10-Q | 10.3 | Lease Agreement between Registrant and Boston Properties Limited partnership, dated May 15, 2018. |
|---|
| 2018-05-04 | 10-Q | 10.1 | Update to Description of Executive Officer Annual Incentive Cash Compensation Program. |
|---|
| 2018-02-27 | 10-K | 10.23 | Commercial Supply Agreement, dated February 22, 2018, by and between the Registrant and Catalent Pharma Solutions, LLC. |
|---|
| 2018-02-27 | 10-K | 10.19 | Third Amendment to Product Agreement, dated December 11, 2017, by and between the Registrant and Patheon Pharmaceuticals Inc. |
|---|
| 2017-08-08 | 10-Q | 10.3 | acad-ex103_94.htm |
|---|
| 2017-08-08 | 10-Q | 10.1 | Description of Outside Director Compensation Program |
|---|
| 2017-05-09 | 10-Q | 10.2 | acad-ex102_7.htm |
|---|
| 2017-05-09 | 10-Q | 10.1 | Description of Outside Director Compensation Program |
|---|
| 2017-02-28 | 10-K | 10.21 | acad-ex1021_729.htm |
|---|
| 2017-02-28 | 10-K | 10.20 | Master Services Agreement |
|---|
| 2017-02-28 | 10-K | 10.6 | 2004 Employee Stock Purchase Plan |
|---|
| 2016-11-07 | 10-Q | 10.2 | acad-ex102_247.htm |
|---|
| 2016-11-07 | 10-Q | 10.1 | Second Amendment to Product Agreement |
|---|
| 2016-08-04 | 10-Q | 10.1 | First Amendment to Product Agreement |
|---|
| 2016-02-29 | 10-K | 10.10 | We are delighted to offer to you the position of |
|---|
| 2016-02-29 | 10-K | 10.4 | NONSTATUTORY STOCK OPTION GRANT NOTICE (2010 EQUITY INCENTIVE PLAN) |
|---|
| 2015-11-05 | 10-Q | 10.2 | Co-operation Agreement |
|---|
| 2015-11-05 | 10-Q | 10.1 | Manufacturing Services Agreement |
|---|
| 2015-05-07 | 10-Q | 10.2 | RE: Retention Bonus Agreement |
|---|
| 2015-05-07 | 10-Q | 10.1 | EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT |
|---|
| 2015-02-26 | 10-K | 10.28 | SUBLEASE AGREEMENT |
|---|
| 2014-08-05 | 10-Q | 10.2 | CHANGE IN CONTROL SEVERANCE BENEFIT PLAN |
|---|
| 2014-08-05 | 10-Q | 10.1 | EXECUTIVE EMPLOYMENT AGREEMENT |
|---|
| 2014-02-27 | 10-K | 10.15 | CHANGE IN CONTROL SEVERANCE BENEFIT PLAN |
|---|
| 2014-02-27 | 10-K | 10.13 | EXECUTIVE EMPLOYMENT AGREEMENT |
|---|
| 2013-11-06 | 10-Q | 10.1 | First Amendment to Lease, dated August 28, 2013, between the Registrant and HCP Torreyana, LLC regarding 11085 Torreyana Road. |
|---|
| 2013-08-06 | 10-Q | 10.1 | Lease Amendment, dated May 22, 2013, between the Registrant and RGH Holdings Limited Partnership, to Standard Industrial/Commercial Single-Tenant Lease-Net, dated August 15, 1997, between the Registrant and R.G. Harris Co. |
|---|
| 2013-03-12 | 10-K | 10.34 | CHANGE IN CONTROL SEVERANCE BENEFIT PLAN |
|---|
| 2013-03-12 | 10-K | 10.33 | Incentive Cash Compensation Program |
|---|
| 2013-03-12 | 10-K | 10.13 | Compensation Program |
|---|
| 2012-11-05 | 10-Q | 10.1 | FIFTH AMENDMENT TO LEASE, DATED SEPTEMBER 19, 2012 |
|---|
| 2012-03-06 | 10-K | 10.23 | SEVENTH AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT |
|---|
| 2011-05-10 | 10-Q | 10.2 | TERMINATION AGREEMENT BY AND BETWEEN REGISTRANT |
|---|
| 2011-05-10 | 10-Q | 10.1 | SIXTH AMENDMENT TO COLLABORATIVE RESEARCH |
|---|
| 2011-03-10 | 10-K | 10.24 | TERMINATION AGREEMENT |
|---|
| 2011-03-10 | 10-K | 10.13 | EMPLOYMENT AGREEMENT |
|---|
| 2011-03-10 | 10-K | 10.6 | FORMS OF AGREEMENT UNDER THE 2010 EQUITY INCENTIVE PLAN |
|---|
| 2010-08-09 | 10-Q | 10.1 | 2010 EQUITY INCENTIVE PLAN |
|---|
| 2010-05-10 | 10-Q | 10.1 | FIFTH AMENDMENT TO COLLABORATION RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTS |
|---|
| 2010-03-09 | 10-K | 10.25 | LEASE AMENDMENT DATED 01/22/2010 |
|---|
| 2010-03-09 | 10-K | 10.21 | AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT |
|---|
| 2010-03-09 | 10-K | 10.7 | ADOPTION AGREEMENT FOR 401(K) PLAN |
|---|
| 2010-03-09 | 10-K | 10.6 | VOLUME SUBMITTER DEFINED CONTRIBUTION PLAN |
|---|
| 2009-08-05 | 10-Q | 10.2 | FOURTH AMENDMENT TO COLLABORATION RESEARCH, DEVELOPMENT AND LICENSE AGREEMENTS |
|---|
| 2009-08-05 | 10-Q | 10.1 | COLLABORATION AND LICENSE AGREEMENT |
|---|
| 2009-05-11 | 10-Q | 10.1 | COLLABORATION & LICENSE AGREEMENT |
|---|
| 2009-03-10 | 10-K | 10.12 | EMPLOYEMENT OFFER LETTER |
|---|